Veklury (remdesivir) for IV use is the first official FDA-approved treatment for COVID-19 requiring hospitalization.
Veklury (remdesivir) for IV use is the first official FDA-approved treatment for COVID-19 requiring hospitalization.
Helpful strategies to address COVID-19-related disruptions in workers’ comp.
What precautions and strategies can keep workers safe?
Managing employee anxiety after isolation.
The anti-malaria drug is no longer deemed effective.
Positive trials bode well for this antiviral.
Saliva samples collected at-home must be sent to the designated lab.
A collection of facts and figures surrounding the COVID-19 pandemic
Update: ACOEM Updates Previous Guidance
The FDA and JAMA think blood from those who recovered from COVID-19 could benefit those still ill.
Testing for COVID-19 antibodies is not a conclusive test for infection.
This is NOT an at-home test. Samples collected at home must be sent to a LabCorp facility.
The FDA is working to expedite the delivery of diagnostic testing for COVID-19.
The FDA’s action surrounding anti-malaria drugs theorized to reduce COVID-19 symptoms.
Will disruptions in manufacturing result in drug shortages?
FDA investigates claims that NSAID use could aggravate COVID-19 symptoms.
COVID-19 drug trials are underway, but the pandemic is disrupting clinical testing.
Information from nearly 15,000 COVID-19 claims broken down by industry, demographics, and more.
An exploration of job loss due to the COVID-19 pandemic.
WCIRB analyzes historic data on economic cycles.
WCIRB Releases Updated May Data
How COVID-19 is impacting healthcare trends.
$25 million each for essential worker and essential business support funds.
With mass gatherings discouraged or temporarily outlawed, many conferences have been canceled or converted to digital formats.
The WCIRB is partnering with workers’ comp organizations across the country
Our response to this pandemic, including business continuity measures.
Cause Code 83 for Pandemic and Nature Code 83 for COVID-19 will impact future reporting for claims impacted by coronavirus.
A Presidential order plans to make temporary telehealth changes more permanent.
A new report on how federal workers’ comp claims have been impacted.
A new Executive Order covers dozens of professions beyond first responders and healthcare workers.
Standards are in place for PPE, social distancing, testing procedures, and more.
Certain occupations require different levels of protection.
COVID-19 claim data was gathered in a survey to understand impacts to comp.
Maximum medical improvement (MME) and impairment rating (IR) evaluations cannot be done remotely.
Lists of compiled information on telehealth, public notices, and more.
Information on layoffs, shutdowns, access to care, and more.
Providers receive more time in light of system disruptions due to COVID-19
Emergency rules expiring April 13th expanded indefinitely.
Healthesystems’ AVP of Advocacy & Compliance discusses the massive state and federal responses to COVID-19 with WorkCompWire.
These provisions expire May 8, 2020, but may be regularly renewed as necessary.
In response to the COVID-19 pandemic, the state issued a delay in adherence.
